Operating Lease, Right-of-Use Asset of Xenon Pharmaceuticals Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xenon Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Xenon Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,960,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Xenon Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,960,000 -$1,298,000 -16% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $7,290,000 -$1,283,000 -15% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $7,617,000 -$1,267,000 -14% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $7,939,000 -$1,254,000 -14% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $8,258,000 -$1,239,000 -13% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $8,573,000 -$1,226,000 -13% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $8,884,000 -$1,213,000 -12% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $9,193,000 -$1,213,000 -12% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $9,497,000 +$1,938,000 +26% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $9,799,000 +$2,069,000 +27% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $10,097,000 +$2,197,000 +28% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $10,406,000 +$2,350,000 +29% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $7,559,000 +$4,592,000 +155% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $7,730,000 +$4,644,000 +150% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,900,000 +$4,694,000 +146% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $8,056,000 +$4,730,000 +142% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $2,967,000 +$2,081,000 +235% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $3,086,000 +$2,057,000 +200% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $3,206,000 +$2,374,000 +285% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $3,326,000 +$2,393,000 +256% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $886,000 -$150,000 -14% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,029,000 -$106,000 -9.3% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $832,000 -$401,000 -33% 31 Mar 2020 10-Q/A 26 May 2020 2020 Q1
Q4 2019 $933,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $1,036,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $1,135,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $1,233,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.